Resistant Cancer Cell Line Collection

Jindrich Cinatl
Dr Petra Joh-Forschungshaus
Frankfurter Stiftung für krebskranke Kinder
Frankfurt am Main, Germany

Wass-Michaelis Research Group
School of Biosciences
University of Kent
Kent, UK
Investigate Data for a single Drug: gefitinib
Gefitinib - Drug Information
Basic information about the drug is displayed below. This has been extracted from the Wikipedia entry for the drug - https://en.wikipedia.org/wiki/Gefitinib
tr>
Gefitinib structure.svg
Gefitinib ball-and-stick.png
Clinical data
Trade names Iressa
AHFS/Drugs.com Monograph
MedlinePlus a607002
Pregnancy
category
US: D (Evidence of risk)
Routes of
administration
Oral
ATC code L01XE02 (WHO)
Pharmacokinetic data
Bioavailability 59%
Protein binding 90%
Biological half-life 6-49 hours
Excretion Faecal
Identifiers
Synonyms cisplatinum, platamin, neoplatin, cismaplat, cis-diamminedichloridoplatinum(II) (CDDP)
CAS Number 184475-35-2
PubChem CID 123631
DrugBank DB00317
ChemSpider 110217
KEGG D01977
ChEBI CHEBI:49668
ChEMBL CHEMBL939
Gefitinib Drug sensitivity Data
The table and barchart show all drug sensitivity data for gefitinib

In the bar chart resistant sub-lines are shown in a lighter shade of the parental cell line